Ullmann Wealth Partners Group LLC purchased a new stake in shares of Oracle Co. (NYSE:ORCL – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,937 shares of the enterprise software provider’s stock, valued at approximately $274,000.
Several other hedge funds have also added to or reduced their stakes in ORCL. Westend Capital Management LLC acquired a new position in Oracle during the 1st quarter valued at about $25,000. POM Investment Strategies LLC bought a new stake in shares of Oracle during the second quarter worth approximately $30,000. Bbjs Financial Advisors LLC bought a new stake in shares of Oracle during the second quarter worth approximately $35,000. Tidemark LLC acquired a new position in Oracle in the fourth quarter valued at approximately $29,000. Finally, Frank Rimerman Advisors LLC bought a new position in Oracle in the fourth quarter valued at approximately $30,000. Institutional investors own 42.44% of the company’s stock.
Oracle Price Performance
Shares of ORCL opened at $161.36 on Friday. The company has a 50 day moving average of $139.50 and a 200-day moving average of $129.55. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 6.68. The stock has a market capitalization of $447.12 billion, a P/E ratio of 43.49, a P/E/G ratio of 2.89 and a beta of 1.01. Oracle Co. has a twelve month low of $99.26 and a twelve month high of $162.34.
Oracle Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, October 24th. Investors of record on Thursday, October 10th will be given a dividend of $0.40 per share. The ex-dividend date is Thursday, October 10th. This represents a $1.60 annualized dividend and a yield of 0.99%. Oracle’s dividend payout ratio (DPR) is presently 43.13%.
Insider Buying and Selling at Oracle
In related news, Director Leon E. Panetta sold 15,000 shares of the firm’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $137.89, for a total value of $2,068,350.00. Following the completion of the transaction, the director now directly owns 58,090 shares of the company’s stock, valued at $8,010,030.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Leon E. Panetta sold 15,000 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $137.89, for a total value of $2,068,350.00. Following the completion of the sale, the director now directly owns 58,090 shares in the company, valued at approximately $8,010,030.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Edward Screven sold 235,918 shares of the business’s stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the transaction, the insider now directly owns 2,626,764 shares in the company, valued at approximately $379,042,045.20. The disclosure for this sale can be found here. Insiders sold a total of 1,862,500 shares of company stock worth $266,776,624 over the last ninety days. 42.80% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
ORCL has been the topic of a number of analyst reports. Morgan Stanley increased their price target on Oracle from $125.00 to $145.00 and gave the company an “equal weight” rating in a research note on Tuesday. Mizuho increased their target price on Oracle from $170.00 to $185.00 and gave the company an “outperform” rating in a research note on Tuesday. UBS Group raised their target price on Oracle from $160.00 to $175.00 and gave the stock a “buy” rating in a report on Tuesday. Barclays upped their price target on Oracle from $160.00 to $172.00 and gave the company an “overweight” rating in a research note on Tuesday. Finally, TD Cowen lifted their price objective on shares of Oracle from $165.00 to $180.00 and gave the stock a “buy” rating in a research note on Tuesday. Eleven analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. According to MarketBeat.com, Oracle currently has an average rating of “Moderate Buy” and a consensus price target of $158.68.
Check Out Our Latest Stock Analysis on ORCL
Oracle Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading
- Five stocks we like better than Oracle
- The Significance of Brokerage Rankings in Stock Selection
- 3 Leveraged ETFs to Multiply Returns
- The Most Important Warren Buffett Stock for Investors: His Own
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- 3 Small Caps With Big Return Potential
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.